Behind the Curtain: How Investors Actually Evaluate Early Stage Deals

​What actually makes an investor say yes at the earliest stages? And what makes them say no before you’ve finished your second slide?

​Join Health2047 for a candid conversation with three investors who are actively deploying capital into early-stage healthcare—with a particular focus on women’s health. We’ll cut through the polished pitch advice and get into the real process: how deals get evaluated, what red flags kill momentum, what founders building in women’s health need to understand about their category, and where missed opportunities still haunt even the most seasoned investors.

​Whether you’re a founder preparing to raise, an investor refining your thesis, or an operator trying to understand how capital decisions get made—this one’s for you.

​Speakers

• ​Warren Templeton, Managing Director, Health2047

• ​Naseem Sayani, Director, Innovator's Circle, Women's Health Access Matters

• ​Delphine O'Rourke, JD, Lead Venture Partner, Portfolia

​Moderated by: Jill Miranda, Strategic Consultant, Health2047